Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Diane Brady on how CEOs should handle a cancer diagnosis. The big story: Reciprocal trade tariffs. The markets: Approaching ...
Inc1mon
Exclusive Conversation Between Accenture CEO Julie Sweet and David Droga: How A ‘Ridiculous’ Leadership Idea Led to a Remarkable Outcome
Hello and welcome to Modern CEO! I’m Stephanie Mehta, CEO and chief content officer of Mansueto Ventures. Each week this newsletter explores inclusive approaches to leadership drawn from ...
moneycontrol.com5d
Accenture CEO Julie Sweet diagnosed with early-stage breast cancer, treatment likely to last 12-16 weeks
Accenture Chief Executive Officer Julie Sweet has been diagnosed with early-stage breast cancer and the treatment is likely to last 12-16 weeks, Moneycontrol has learnt. “I was very recently ...
Accenture CEO Julie Sweet sells $3.47 million in shares
Julie Spellman Sweet, Chair and CEO of Accenture plc (NYSE:ACN), recently sold a significant portion of her holdings in the company. According to a regulatory filing, Sweet disposed of 7,793 Class A ...
Indiatimes5d
Accenture CEO Julie Sweet diagnosed with cancer, to undergo surgery next week
Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable condition, she will undergo surgery and radiation treatment while continuing ...
AOL5d
Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...